TIGENIX NV

Profile

Company Names

TIGENIX NV

Addresses

ROMEINSE STRAAT 12 BOX 2, 3001, LEUVEN, C9 3001

ROMEINSE STRAAT 12, BOX 2, 3001, LEUVEN, C9 00000

Phone Numbers

+32 16 39 79 37
+34918060946

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

BELGIUM

Total Amount Raised:

$8,566,122.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-11-16 
$25,902.00 
$195,412.00 
$169,510.00 
Equity 
1
2013-07-18 
$8,540,220.00 
$8,540,220.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JUNE 
 
ALMENOFF 
DIRECTOR
OHR PHARMACEUTICAL INC   |  TIGENIX NV   |  REDHILL BIOPHARMA LTD.   |  TENAX THERAPEUTICS, INC.
EDUARDO 
 
BRAVO 
EXECUTIVE OFFICER, DIRECTOR
TIGENIX NV
EDUARDO 
 
BRAVO FERNANDEZ DE ARAOZ 
EXECUTIVE OFFICER, DIRECTOR
TIGENIX NV
CLAUDIA 
 
D-AUGUSTA 
EXECUTIVE OFFICER
TIGENIX NV
WILFRIED 
 
DALEMANS 
EXECUTIVE OFFICER
TIGENIX NV
WILLY 
 
DURON 
DIRECTOR
TIGENIX NV
RUSSELL 
 
GREIG 
DIRECTOR
TIGENIX NV   |  MERUS N.V.   |  BIOMX INC.
MARIA 
DOLORES PASCUAL 
MARTINEZ 
EXECUTIVE OFFICER
TIGENIX NV
MARIE PAULE 
 
RICHARD 
EXECUTIVE OFFICER
TIGENIX NV
GUIDO 
 
SCHOPEN 
EXECUTIVE OFFICER
TIGENIX NV
JEAN 
 
STEPHENNE 
DIRECTOR
TIGENIX NV
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-01-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2017-11-16 
2013-07-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHARDAN CAPITAL MARKETS LLC
120128